Patient Information Leaflets of Drugs Used in Cardiometabolic Disorders: Suitability for Use by Older Persons
In the European Union, all medicines must include appropriate labelling and the respective patient information leaflet (PIL), which is the most reachable source of medicine’s information for patients. This document includes a set of information understandable by their potential users and complementa...
Main Authors: | Margarida Espírito-Santo, Tânia Nascimento, Ezequiel Pinto, M. Dulce Estêvão |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-02-01
|
Series: | Portuguese Journal of Public Health |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/528664 |
Similar Items
-
Readability of information imprinted in patient information leaflets (PILs) in Saudi Arabia: The case of antihypertensive medications
by: Aljoharah M Algabbani, et al.
Published: (2022-12-01) -
Could paper package leaflet be left out from hospital products?
by: Kadri Sirkas, et al.
Published: (2022-09-01) -
Role of Information Anxiety and Information Load on Processing of Prescription Drug Information Leaflets
by: Shweta S. Bapat, et al.
Published: (2017-10-01) -
On the user's side: definitions in Italian and British patient information leaflets
by: Patrizia Pierini
Published: (2015-09-01) -
Nominalization in Arabic translations of patient information leaflets
by: Hala Sharkas
Published: (2024-03-01)